| abstract |
The present invention patent comprises a process that describes the use of synthetic immunoreactive peptides for the development of a kit for the immunodiagnostic test of cryptococcosis, based on the selection of synthetic peptides derived from the identification of immunoreactive proteins from Cryptococcus spp., By proteomic and bioinformatics analyzes, followed by peptide synthesis and immunoassays, aiming at its use as the most efficient immunodiagnostic test for human cryptococcosis, in view of the high specificity and sensitivity of these antigens. |